These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 34722259)

  • 1. m
    Yu N; Wu Y; Wei Q; Li X; Li M; Wu W
    Am J Cancer Res; 2024; 14(7):3565-3583. PubMed ID: 39113868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PSME3 promotes lung adenocarcinoma development by regulating the TGF-β/SMAD signaling pathway.
    Wang S; Li Y; Jin K; Suda K; Li R; Zhang H; Tian H
    Transl Lung Cancer Res; 2024 Jun; 13(6):1331-1345. PubMed ID: 38973962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BZW2 promotes malignant progression in lung adenocarcinoma through enhancing the ubiquitination and degradation of GSK3β.
    Jin K; Li Y; Wei R; Liu Y; Wang S; Tian H
    Cell Death Discov; 2024 Feb; 10(1):105. PubMed ID: 38424042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucin 1 promotes tumor progression through activating WNT/β-catenin signaling pathway in intrahepatic cholangiocarcinoma.
    Song F; Chen FY; Wu SY; Hu B; Liang XL; Yang HQ; Cheng JW; Wang PX; Guo W; Zhou J; Fan J; Chen Z; Yang XR
    J Cancer; 2021; 12(23):6937-6947. PubMed ID: 34729096
    [No Abstract]   [Full Text] [Related]  

  • 5. Integrated bioinformatics analysis reveals dynamic candidate genes and signaling pathways involved in the progression and prognosis of diffuse large B-cell lymphoma.
    Charwudzi A; Meng Y; Hu L; Ding C; Pu L; Li Q; Xu M; Zhai Z; Xiong S
    PeerJ; 2021; 9():e12394. PubMed ID: 34760386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Bruton tyrosine kinase inhibitor-resistance gene signature predicts prognosis and identifies TRIP13 as a potential therapeutic target in diffuse large B-cell lymphoma.
    Ding Y; Huang K; Sun C; Liu Z; Zhu J; Jiao X; Liao Y; Feng X; Guo J; Zhu C; Zhai Z; Xiong S
    Sci Rep; 2024 Sep; 14(1):21184. PubMed ID: 39261532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TEM8 in Oncogenesis: Protein Biology, Pre-Clinical Agents, and Clinical Rationale.
    Kareff SA; Corbett V; Hallenbeck P; Chauhan A
    Cells; 2023 Nov; 12(22):. PubMed ID: 37998358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vessel size as a marker of survival in estrogen receptor positive breast cancer.
    Milosevic V; Edelmann RJ; Winge I; Strell C; Mezheyeuski A; Knutsvik G; Askeland C; Wik E; Akslen LA; Östman A
    Breast Cancer Res Treat; 2023 Jul; 200(2):293-304. PubMed ID: 37222874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome-Based Traits of Radioresistant Sublines of Non-Small Cell Lung Cancer Cells.
    Pustovalova M; Malakhov P; Guryanova A; Sorokin M; Suntsova M; Buzdin A; Osipov AN; Leonov S
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769365
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Ma W; Wang C; Li R; Han Z; Jiang Y; Zhang X; Divisi D; Capobianco E; Zhang L; Dong W
    Transl Lung Cancer Res; 2022 Sep; 11(9):1912-1925. PubMed ID: 36248333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving role of seneca valley virus and its biomarker TEM8/ANTXR1 in cancer therapeutics.
    Corbett V; Hallenbeck P; Rychahou P; Chauhan A
    Front Mol Biosci; 2022; 9():930207. PubMed ID: 36090051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmembrane Protein ANTXR1 Regulates
    Jin T; Zhang Z; Han Y; Li D; Liu J; Jiang M; Zhu J; Kurita R; Nakamura Y; Hu F; Xu Y; Fang X; Huang S; Sun Z
    J Immunol Res; 2022; 2022():8440422. PubMed ID: 35942209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANTXR1 as a potential prognostic biomarker for hepatitis B virus-related hepatocellular carcinoma identified by a weighted gene correlation network analysis.
    Si T; Ning X; Chen H; Hu Z; Dun L; Zheng N; Huang P; Yang L; Yi P
    J Gastrointest Oncol; 2021 Dec; 12(6):3079-3092. PubMed ID: 35070431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Endothelial Marker 8 Promotes Proliferation and Metastasis
    Ding C; Liu J; Zhang J; Wan Y; Hu L; Charwudzi A; Zhan H; Meng Y; Zheng H; Wang H; Wang Y; Gao L; Hu X; Li J; Xiong S
    Front Oncol; 2021; 11():712371. PubMed ID: 34722259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling.
    Jiang N; Zou C; Zhu Y; Luo Y; Chen L; Lei Y; Tang K; Sun Y; Zhang W; Li S; He Q; Zhou J; Chen Y; Luo J; Jiang W; Ke Z
    Theranostics; 2020; 10(6):2553-2570. PubMed ID: 32194819
    [No Abstract]   [Full Text] [Related]  

  • 16. STAT1-induced upregulation of LINC00467 promotes the proliferation migration of lung adenocarcinoma cells by epigenetically silencing DKK1 to activate Wnt/β-catenin signaling pathway.
    Yang J; Liu Y; Mai X; Lu S; Jin L; Tai X
    Biochem Biophys Res Commun; 2019 Jun; 514(1):118-126. PubMed ID: 31027730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ARHGAP9 knockdown promotes lung adenocarcinoma metastasis by activating Wnt/β-catenin signaling pathway via suppressing DKK2.
    Song W; Wu X; Cheng C; Li D; Chen J; Zhang W
    Genomics; 2023 Sep; 115(5):110684. PubMed ID: 37454937
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.